Explore ViiV Healthcare

amfAR TREAT Asia

Photo courtesy of Kevin Tachman/TREAT Asia


My name is Annette Sohn and I am Vice President of amfAR, The Foundation for AIDS Research, and Director of TREAT Asia, a Bangkok-based programme of amfAR. Today, I am pleased to tell you about how our ground-breaking collaboration with ViiV Healthcare’s Paediatric Innovation Seed Fund is building on our regional paediatric programme to optimise treatment for infants, children and adolescents living with HIV in the Asia-Pacific region and to develop strategies for life-long care.

Our regional paediatric programme, which began in 2005, invests in the future of people living with HIV in the Asia-Pacific region by supporting projects focused on children and adolescents, the paediatricians who care for them and the researchers working to improve their lives through evidence-based research. It is comprised of 20 sites in six countries, with Asia’s largest database of children and adolescents living with HIV.

Key Facts

Project: A multi-year partnership designed to optimise the quality of healthcare for infants, children and adolescents living with HIV across Asia.

Run by: TREAT Asia/amfAR

Region: Asia-Pacific

Population: Infants, children and adolescents living with HIV

Challenges: High first-line antiretroviral therapy (ART) failure rates among children; Limited availability of ART regimens that can be dosed and delivered to newborns and young children, and that are safe to use during growth and development; Poor access to once-daily fixed-dose combination medicines and third-line options for adolescents; Gaps in research capacity and higher-level training for paediatric HIV providers.

Activities: Conducting integrated and innovative programmes in research, provider education and global advocacy, with a focus on treatment failure, the emergence of drug-resistance and optimising antiretroviral sequencing for children living with HIV, among other important considerations for paediatric populations in the region and across the globe.